Loading company…
Shanghai-based developer of cancer supportive care treatments that reduce dose-limiting side effects of anti-cancer therapies.
Founded in 2018 and headquartered in Shanghai, China, OnQuality Pharmaceuticals LLC develops targeted cancer supportive care drugs to prevent and manage dose-limiting toxicities from anti-cancer medications. Its founders are Hong Tang, Jie Luo and Shiyi Zhang. In March 2021 the company raised USD 20.00 mn in Series A funding from investors including BioTrack Capital, CASH Capital, Frees Fund, MPC, Shiyu Capital and Sinovation Ventures. It plans a Phase II clinical trial for its compound OQL011.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in